GENII Acquires iVention

GENII Acquires iVention GSG GENII Software Group acquires iVention, a leading provider of cloud-based laboratory execution systems GSG GENII Software Group ("GENII") announced the acquisition of iVention. iVention serves laboratories across a wide range of industries with the powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for laboratory processes. Headquartered in Zwolle, Netherlands, iVention deploys its solutions through a cloud-based laboratory automation platform that consolidates all core laboratory automation capabilities in a single system. As a comprehensive laboratory management tool, iLES can increase efficiency and quality even in highly regulated environments by streamlining workflows and managing and automating both research and routine operations. With iLES, laboratories benefit from automatic updates, unlock real-time information, ensure data integrity and regulatory compliance. Through efficient process automation and reduced manual data processing, it delivers time and cost savings. As GENII continues to develop clinical and non-clinical software solutions for the laboratory sector, iVention joins other specialists such as ICD and Blomesystem as part of GENII's Laboratories business unit. As part of a larger laboratory business unit, iVention will leverage GENII's laboratory customer base and geographic footprint, receive investment to achieve its goal of becoming a top 5 global iLES solution, compete directly with established players, and gain market share as a preferred modern implementation. Oscar Kox, Chief Executive Officer of iVention, said: "We are delighted to join GENII and the Laboratories team. GENII has dedicated itself to this sector, and the opportunity to be part of it using our iLES technology platform across this industry is very exciting. I believe we are stronger together. With our combined sector expertise, our best-in-class product will enable us to shape the next era of advanced, automated technology for laboratories in the years ahead." Matthias Siekmann, Chief Executive Officer of GENII Group, said: "Our acquisition of iVention furthers GENII's strategy of being the best home for leading niche enterprise software businesses in the sector. Together, we will take a strong step to transform the laboratory automation world and make iVention a leading product with the most modern technology, future-ready and financially supported by GENII." Source